Share Price and Basic Stock Data
Last Updated: December 24, 2025, 6:44 pm
| PEG Ratio | 0.66 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Balmer Lawrie Investment Ltd operates as a Non-Banking Financial Company (NBFC) with a current market capitalization of ₹1,620 Cr. The company reported a total revenue of ₹2,335 Cr for the fiscal year ending March 2023, reflecting a growth trajectory from ₹2,074 Cr in March 2022. The revenue is anticipated to rise further, with reported figures of ₹2,373 Cr for March 2024 and ₹2,545 Cr for March 2025. The quarterly sales figures indicate fluctuations, with the highest sales of ₹649 Cr recorded in June 2022, dropping to a low of ₹516 Cr in December 2022, before recovering to ₹610 Cr in March 2023. The latest quarterly sales for June 2025 stood at ₹683 Cr, showcasing a positive trend. The company’s ability to maintain consistent sales and revenue growth is indicative of its operational resilience in a competitive financial landscape.
Profitability and Efficiency Metrics
Balmer Lawrie’s profitability metrics demonstrate a robust operational framework, with a reported net profit of ₹265 Cr for the trailing twelve months (TTM), translating to an earnings per share (EPS) of ₹7.73. The operating profit margin (OPM) stood at 13% for the most recent fiscal year, reflecting effective cost management strategies, although it varied across quarters, reaching a peak of 16% in March 2024. The interest coverage ratio (ICR) of 14.04x indicates strong earnings relative to interest obligations, suggesting that the company can comfortably meet its debt commitments. The return on equity (ROE) is reported at 13.2%, while the return on capital employed (ROCE) stands at 17.2%, both of which are favorable compared to typical sector ranges, indicating efficient use of capital. However, fluctuations in quarterly net profits, particularly a dip in June 2024, require close monitoring for sustained profitability.
Balance Sheet Strength and Financial Ratios
Balmer Lawrie’s balance sheet reflects a solid financial position, with total assets reported at ₹3,204 Cr and total liabilities at ₹3,204 Cr as of March 2025. The company maintains a low debt level, with borrowings of ₹237 Cr and a debt-to-equity ratio of 0.05, which is significantly lower than the industry average, indicating a conservative approach to leveraging. Reserves have increased to ₹1,337 Cr, providing a cushion for future growth and stability. The current ratio is reported at 2.49, suggesting a strong liquidity position, which is favorable for meeting short-term obligations. Furthermore, the price-to-book value (P/BV) ratio of 1.09x indicates that the stock is trading close to its book value, which can be attractive for value investors. However, the company must manage its cash conversion cycle, which stood at 46 days, to optimize working capital and enhance liquidity.
Shareholding Pattern and Investor Confidence
The shareholding structure of Balmer Lawrie indicates a stable promoter presence, with promoters holding 59.67% of the company. Institutional investment is low, with foreign institutional investors (FIIs) owning 1.10% and domestic institutional investors (DIIs) holding just 0.03%. Public shareholding accounts for 39.20%, with a total of 51,746 shareholders as of September 2025. The gradual increase in FIIs from 0.66% in December 2022 to 1.10% in September 2025 suggests a growing interest from foreign investors, which could enhance market confidence. The company’s consistent dividend payout, reported at 56% for March 2025, signals a commitment to returning value to shareholders. However, the low institutional ownership may indicate a lack of broader market recognition, which could affect liquidity and stock performance.
Outlook, Risks, and Final Insight
Balmer Lawrie’s outlook appears positive, driven by consistent revenue growth and strong profitability metrics. The company’s low leverage and healthy liquidity position bolster its financial stability. However, risks such as fluctuations in quarterly earnings and low institutional investor interest could pose challenges. Additionally, the company’s ability to manage its cash conversion cycle effectively will be crucial for sustaining operational efficiency. If Balmer Lawrie can leverage its strong balance sheet to pursue strategic growth opportunities while maintaining profitability, it is likely to enhance shareholder value. Conversely, any adverse market conditions or operational setbacks could impact its financial performance. Investors should closely monitor the company’s quarterly results and market dynamics to make informed decisions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minolta Finance Ltd | 14.9 Cr. | 1.49 | 1.91/1.00 | 1.07 | 0.00 % | 0.40 % | 0.09 % | 1.00 | |
| Money Masters Leasing & Finance Ltd | 7.83 Cr. | 0.78 | 8.75/0.75 | 23.0 | 1.57 | 0.00 % | 4.42 % | 3.94 % | 1.00 |
| Moneyboxx Finance Ltd | 459 Cr. | 63.0 | 130/59.1 | 40.1 | 0.00 % | 8.65 % | 0.58 % | 10.0 | |
| Moongipa Capital Finance Ltd | 14.8 Cr. | 16.1 | 34.4/15.0 | 11.0 | 26.6 | 0.00 % | 12.1 % | 9.43 % | 10.0 |
| Morarka Finance Ltd | 37.8 Cr. | 84.0 | 162/74.8 | 20.2 | 238 | 1.19 % | 2.46 % | 2.17 % | 10.0 |
| Industry Average | 29,073.97 Cr | 456.06 | 53.42 | 522.46 | 0.22% | 15.80% | 8.84% | 8.50 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 649 | 553 | 516 | 610 | 594 | 587 | 587 | 579 | 641 | 642 | 633 | 611 | 683 |
| Expenses | 587 | 513 | 464 | 556 | 528 | 511 | 511 | 485 | 574 | 569 | 547 | 514 | 598 |
| Operating Profit | 62 | 40 | 52 | 55 | 67 | 77 | 76 | 94 | 66 | 73 | 86 | 97 | 86 |
| OPM % | 10% | 7% | 10% | 9% | 11% | 13% | 13% | 16% | 10% | 11% | 14% | 16% | 13% |
| Other Income | 24 | 24 | 15 | 35 | 24 | 28 | 27 | 30 | 31 | 29 | 22 | 33 | 25 |
| Interest | 5 | 4 | 5 | 5 | 6 | 5 | 5 | 6 | 6 | 5 | 9 | 6 | 7 |
| Depreciation | 14 | 14 | 14 | 14 | 15 | 14 | 14 | 15 | 14 | 14 | 15 | 16 | 14 |
| Profit before tax | 68 | 46 | 47 | 70 | 70 | 85 | 83 | 103 | 76 | 82 | 84 | 107 | 89 |
| Tax % | 17% | 24% | 22% | 38% | 18% | 25% | 19% | 27% | 15% | 24% | 24% | 30% | 22% |
| Net Profit | 56 | 35 | 37 | 44 | 57 | 64 | 68 | 75 | 65 | 63 | 64 | 75 | 69 |
| EPS in Rs | 1.60 | 1.02 | 1.10 | 1.27 | 1.66 | 1.83 | 1.94 | 2.14 | 1.86 | 1.82 | 1.88 | 2.17 | 2.01 |
Last Updated: August 19, 2025, 10:45 pm
Below is a detailed analysis of the quarterly data for Balmer Lawrie Investment Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 683.00 Cr.. The value appears strong and on an upward trend. It has increased from 611.00 Cr. (Mar 2025) to 683.00 Cr., marking an increase of 72.00 Cr..
- For Expenses, as of Jun 2025, the value is 598.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 514.00 Cr. (Mar 2025) to 598.00 Cr., marking an increase of 84.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 86.00 Cr.. The value appears to be declining and may need further review. It has decreased from 97.00 Cr. (Mar 2025) to 86.00 Cr., marking a decrease of 11.00 Cr..
- For OPM %, as of Jun 2025, the value is 13.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Mar 2025) to 13.00%, marking a decrease of 3.00%.
- For Other Income, as of Jun 2025, the value is 25.00 Cr.. The value appears to be declining and may need further review. It has decreased from 33.00 Cr. (Mar 2025) to 25.00 Cr., marking a decrease of 8.00 Cr..
- For Interest, as of Jun 2025, the value is 7.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 14.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 2.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 89.00 Cr.. The value appears to be declining and may need further review. It has decreased from 107.00 Cr. (Mar 2025) to 89.00 Cr., marking a decrease of 18.00 Cr..
- For Tax %, as of Jun 2025, the value is 22.00%. The value appears to be improving (decreasing) as expected. It has decreased from 30.00% (Mar 2025) to 22.00%, marking a decrease of 8.00%.
- For Net Profit, as of Jun 2025, the value is 69.00 Cr.. The value appears to be declining and may need further review. It has decreased from 75.00 Cr. (Mar 2025) to 69.00 Cr., marking a decrease of 6.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 2.01. The value appears to be declining and may need further review. It has decreased from 2.17 (Mar 2025) to 2.01, marking a decrease of 0.16.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:07 am
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,817 | 1,573 | 1,563 | 2,074 | 2,335 | 2,373 | 2,545 | 2,566 |
| Expenses | 1,547 | 1,347 | 1,413 | 1,883 | 2,110 | 2,024 | 2,193 | 2,227 |
| Operating Profit | 270 | 226 | 150 | 191 | 225 | 349 | 352 | 339 |
| OPM % | 15% | 14% | 10% | 9% | 10% | 15% | 14% | 13% |
| Other Income | 58 | 59 | 79 | 65 | 81 | 52 | 85 | 107 |
| Interest | 7 | 15 | 12 | 14 | 18 | 22 | 27 | 29 |
| Depreciation | 30 | 52 | 55 | 57 | 57 | 59 | 60 | 62 |
| Profit before tax | 290 | 218 | 162 | 186 | 232 | 319 | 350 | 356 |
| Tax % | 30% | 26% | 26% | 26% | 26% | 24% | 24% | |
| Net Profit | 202 | 161 | 121 | 137 | 172 | 242 | 267 | 265 |
| EPS in Rs | 5.79 | 4.76 | 3.59 | 3.97 | 5.00 | 6.96 | 7.73 | 7.72 |
| Dividend Payout % | 59% | 79% | 106% | 75% | 66% | 55% | 56% |
YoY Net Profit Growth
| Year | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -20.30% | -24.84% | 13.22% | 25.55% | 40.70% | 10.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | -4.55% | 38.07% | 12.32% | 15.15% | -30.37% |
Balmer Lawrie Investment Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2019-2020 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | 7% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | 26% |
| TTM: | 2% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 18% |
| 3 Years: | 30% |
| 1 Year: | -3% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 11% |
| 3 Years: | 12% |
| Last Year: | 13% |
Last Updated: September 5, 2025, 2:36 pm
Balance Sheet
Last Updated: December 4, 2025, 2:29 am
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
| Reserves | 1,052 | 1,081 | 1,076 | 1,094 | 1,117 | 1,199 | 1,354 | 1,337 |
| Borrowings | 81 | 122 | 125 | 122 | 121 | 113 | 106 | 237 |
| Other Liabilities | 1,266 | 1,256 | 1,304 | 1,340 | 1,540 | 1,691 | 1,723 | 1,797 |
| Total Liabilities | 2,420 | 2,482 | 2,527 | 2,578 | 2,801 | 3,025 | 3,204 | 3,393 |
| Fixed Assets | 568 | 770 | 767 | 767 | 760 | 751 | 737 | 789 |
| CWIP | 117 | 24 | 32 | 11 | 28 | 52 | 67 | 79 |
| Investments | 325 | 375 | 386 | 436 | 518 | 565 | 632 | 669 |
| Other Assets | 1,410 | 1,313 | 1,341 | 1,364 | 1,495 | 1,657 | 1,769 | 1,855 |
| Total Assets | 2,420 | 2,482 | 2,527 | 2,578 | 2,801 | 3,025 | 3,204 | 3,393 |
Below is a detailed analysis of the balance sheet data for Balmer Lawrie Investment Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 22.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 22.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,337.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,354.00 Cr. (Mar 2025) to 1,337.00 Cr., marking a decrease of 17.00 Cr..
- For Borrowings, as of Sep 2025, the value is 237.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 106.00 Cr. (Mar 2025) to 237.00 Cr., marking an increase of 131.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,797.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,723.00 Cr. (Mar 2025) to 1,797.00 Cr., marking an increase of 74.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,393.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,204.00 Cr. (Mar 2025) to 3,393.00 Cr., marking an increase of 189.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 789.00 Cr.. The value appears strong and on an upward trend. It has increased from 737.00 Cr. (Mar 2025) to 789.00 Cr., marking an increase of 52.00 Cr..
- For CWIP, as of Sep 2025, the value is 79.00 Cr.. The value appears strong and on an upward trend. It has increased from 67.00 Cr. (Mar 2025) to 79.00 Cr., marking an increase of 12.00 Cr..
- For Investments, as of Sep 2025, the value is 669.00 Cr.. The value appears strong and on an upward trend. It has increased from 632.00 Cr. (Mar 2025) to 669.00 Cr., marking an increase of 37.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,855.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,769.00 Cr. (Mar 2025) to 1,855.00 Cr., marking an increase of 86.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,393.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,204.00 Cr. (Mar 2025) to 3,393.00 Cr., marking an increase of 189.00 Cr..
Notably, the Reserves (1,337.00 Cr.) exceed the Borrowings (237.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Free Cash Flow | 189.00 | 104.00 | 25.00 | 69.00 | 104.00 | 236.00 | 246.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 56 | 63 | 67 | 55 | 56 | 66 | 69 |
| Inventory Days | 47 | 58 | 58 | 51 | 47 | 47 | 43 |
| Days Payable | 0 | 88 | 99 | 68 | 69 | 75 | 66 |
| Cash Conversion Cycle | 102 | 33 | 27 | 38 | 35 | 37 | 46 |
| Working Capital Days | 42 | 51 | 32 | 51 | 41 | 42 | 62 |
| ROCE % | 13% | 9% | 11% | 13% | 17% | 17% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 7.73 | 75.68 | 49.98 | 39.88 | 35.92 |
| Diluted EPS (Rs.) | 7.73 | 75.68 | 49.98 | 39.88 | 35.92 |
| Cash EPS (Rs.) | 11.82 | 119.31 | 75.86 | 66.88 | 64.41 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 61.98 | 549.97 | 500.91 | 788.73 | 777.64 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 61.98 | 549.97 | 500.91 | 788.73 | 777.64 |
| Revenue From Operations / Share (Rs.) | 113.81 | 1057.87 | 1048.95 | 928.38 | 692.07 |
| PBDIT / Share (Rs.) | 16.78 | 164.10 | 110.61 | 94.86 | 88.56 |
| PBIT / Share (Rs.) | 14.06 | 137.44 | 85.02 | 69.73 | 63.78 |
| PBT / Share (Rs.) | 12.87 | 127.51 | 76.94 | 63.60 | 58.41 |
| Net Profit / Share (Rs.) | 9.10 | 92.65 | 50.28 | 41.74 | 39.62 |
| NP After MI And SOA / Share (Rs.) | 7.73 | 75.68 | 49.98 | 39.88 | 35.92 |
| PBDIT Margin (%) | 14.74 | 15.51 | 10.54 | 10.21 | 12.79 |
| PBIT Margin (%) | 12.35 | 12.99 | 8.10 | 7.51 | 9.21 |
| PBT Margin (%) | 11.30 | 12.05 | 7.33 | 6.85 | 8.43 |
| Net Profit Margin (%) | 7.99 | 8.75 | 4.79 | 4.49 | 5.72 |
| NP After MI And SOA Margin (%) | 6.79 | 7.15 | 4.76 | 4.29 | 5.18 |
| Return on Networth / Equity (%) | 12.47 | 13.76 | 9.97 | 7.92 | 7.26 |
| Return on Capital Employeed (%) | 12.47 | 13.21 | 8.76 | 7.56 | 7.09 |
| Return On Assets (%) | 5.36 | 5.55 | 3.96 | 3.43 | 3.15 |
| Long Term Debt / Equity (X) | 0.05 | 0.05 | 0.07 | 0.07 | 0.08 |
| Total Debt / Equity (X) | 0.05 | 0.06 | 0.08 | 0.08 | 0.08 |
| Asset Turnover Ratio (%) | 0.81 | 0.80 | 0.86 | 0.05 | 0.06 |
| Current Ratio (X) | 2.49 | 2.29 | 2.29 | 2.54 | 2.51 |
| Quick Ratio (X) | 2.22 | 2.02 | 1.98 | 2.16 | 2.20 |
| Inventory Turnover Ratio (X) | 13.09 | 11.79 | 7.88 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 49.14 | 43.60 | 60.02 | 95.29 | 104.40 |
| Dividend Payout Ratio (CP) (%) | 36.37 | 32.24 | 39.70 | 58.45 | 61.77 |
| Earning Retention Ratio (%) | 50.86 | 56.40 | 39.98 | 4.71 | -4.40 |
| Cash Earning Retention Ratio (%) | 63.63 | 67.76 | 60.30 | 41.55 | 38.23 |
| Interest Coverage Ratio (X) | 14.04 | 16.52 | 13.69 | 15.49 | 16.50 |
| Interest Coverage Ratio (Post Tax) (X) | 8.62 | 10.33 | 7.22 | 7.82 | 8.38 |
| Enterprise Value (Cr.) | 1724.29 | 1534.20 | 1027.01 | 1008.40 | 1085.04 |
| EV / Net Operating Revenue (X) | 0.68 | 0.65 | 0.44 | 0.48 | 0.70 |
| EV / EBITDA (X) | 4.63 | 4.21 | 4.18 | 4.79 | 5.52 |
| MarketCap / Net Operating Revenue (X) | 0.59 | 0.57 | 0.33 | 0.39 | 0.67 |
| Retention Ratios (%) | 50.85 | 56.39 | 39.97 | 4.70 | -4.40 |
| Price / BV (X) | 1.09 | 1.11 | 0.70 | 0.73 | 0.94 |
| Price / Net Operating Revenue (X) | 0.59 | 0.57 | 0.33 | 0.39 | 0.67 |
| EarningsYield | 0.11 | 0.12 | 0.14 | 0.10 | 0.07 |
After reviewing the key financial ratios for Balmer Lawrie Investment Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 10.00 (Mar 24) to 1.00, marking a decrease of 9.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 7.73. This value is within the healthy range. It has decreased from 75.68 (Mar 24) to 7.73, marking a decrease of 67.95.
- For Diluted EPS (Rs.), as of Mar 25, the value is 7.73. This value is within the healthy range. It has decreased from 75.68 (Mar 24) to 7.73, marking a decrease of 67.95.
- For Cash EPS (Rs.), as of Mar 25, the value is 11.82. This value is within the healthy range. It has decreased from 119.31 (Mar 24) to 11.82, marking a decrease of 107.49.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 61.98. It has decreased from 549.97 (Mar 24) to 61.98, marking a decrease of 487.99.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 61.98. It has decreased from 549.97 (Mar 24) to 61.98, marking a decrease of 487.99.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 113.81. It has decreased from 1,057.87 (Mar 24) to 113.81, marking a decrease of 944.06.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 16.78. This value is within the healthy range. It has decreased from 164.10 (Mar 24) to 16.78, marking a decrease of 147.32.
- For PBIT / Share (Rs.), as of Mar 25, the value is 14.06. This value is within the healthy range. It has decreased from 137.44 (Mar 24) to 14.06, marking a decrease of 123.38.
- For PBT / Share (Rs.), as of Mar 25, the value is 12.87. This value is within the healthy range. It has decreased from 127.51 (Mar 24) to 12.87, marking a decrease of 114.64.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 9.10. This value is within the healthy range. It has decreased from 92.65 (Mar 24) to 9.10, marking a decrease of 83.55.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7.73. This value is within the healthy range. It has decreased from 75.68 (Mar 24) to 7.73, marking a decrease of 67.95.
- For PBDIT Margin (%), as of Mar 25, the value is 14.74. This value is within the healthy range. It has decreased from 15.51 (Mar 24) to 14.74, marking a decrease of 0.77.
- For PBIT Margin (%), as of Mar 25, the value is 12.35. This value is within the healthy range. It has decreased from 12.99 (Mar 24) to 12.35, marking a decrease of 0.64.
- For PBT Margin (%), as of Mar 25, the value is 11.30. This value is within the healthy range. It has decreased from 12.05 (Mar 24) to 11.30, marking a decrease of 0.75.
- For Net Profit Margin (%), as of Mar 25, the value is 7.99. This value is within the healthy range. It has decreased from 8.75 (Mar 24) to 7.99, marking a decrease of 0.76.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.79. This value is below the healthy minimum of 8. It has decreased from 7.15 (Mar 24) to 6.79, marking a decrease of 0.36.
- For Return on Networth / Equity (%), as of Mar 25, the value is 12.47. This value is below the healthy minimum of 15. It has decreased from 13.76 (Mar 24) to 12.47, marking a decrease of 1.29.
- For Return on Capital Employeed (%), as of Mar 25, the value is 12.47. This value is within the healthy range. It has decreased from 13.21 (Mar 24) to 12.47, marking a decrease of 0.74.
- For Return On Assets (%), as of Mar 25, the value is 5.36. This value is within the healthy range. It has decreased from 5.55 (Mar 24) to 5.36, marking a decrease of 0.19.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.05.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.05. This value is within the healthy range. It has decreased from 0.06 (Mar 24) to 0.05, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.81. It has increased from 0.80 (Mar 24) to 0.81, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 2.49. This value is within the healthy range. It has increased from 2.29 (Mar 24) to 2.49, marking an increase of 0.20.
- For Quick Ratio (X), as of Mar 25, the value is 2.22. This value exceeds the healthy maximum of 2. It has increased from 2.02 (Mar 24) to 2.22, marking an increase of 0.20.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 13.09. This value exceeds the healthy maximum of 8. It has increased from 11.79 (Mar 24) to 13.09, marking an increase of 1.30.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 49.14. This value is within the healthy range. It has increased from 43.60 (Mar 24) to 49.14, marking an increase of 5.54.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 36.37. This value is within the healthy range. It has increased from 32.24 (Mar 24) to 36.37, marking an increase of 4.13.
- For Earning Retention Ratio (%), as of Mar 25, the value is 50.86. This value is within the healthy range. It has decreased from 56.40 (Mar 24) to 50.86, marking a decrease of 5.54.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 63.63. This value is within the healthy range. It has decreased from 67.76 (Mar 24) to 63.63, marking a decrease of 4.13.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 14.04. This value is within the healthy range. It has decreased from 16.52 (Mar 24) to 14.04, marking a decrease of 2.48.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 8.62. This value is within the healthy range. It has decreased from 10.33 (Mar 24) to 8.62, marking a decrease of 1.71.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,724.29. It has increased from 1,534.20 (Mar 24) to 1,724.29, marking an increase of 190.09.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.68, marking an increase of 0.03.
- For EV / EBITDA (X), as of Mar 25, the value is 4.63. This value is below the healthy minimum of 5. It has increased from 4.21 (Mar 24) to 4.63, marking an increase of 0.42.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 24) to 0.59, marking an increase of 0.02.
- For Retention Ratios (%), as of Mar 25, the value is 50.85. This value is within the healthy range. It has decreased from 56.39 (Mar 24) to 50.85, marking a decrease of 5.54.
- For Price / BV (X), as of Mar 25, the value is 1.09. This value is within the healthy range. It has decreased from 1.11 (Mar 24) to 1.09, marking a decrease of 0.02.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 24) to 0.59, marking an increase of 0.02.
- For EarningsYield, as of Mar 25, the value is 0.11. This value is below the healthy minimum of 5. It has decreased from 0.12 (Mar 24) to 0.11, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Balmer Lawrie Investment Ltd:
- Net Profit Margin: 7.99%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12.47% (Industry Average ROCE: 15.8%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 12.47% (Industry Average ROE: 8.84%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 8.62
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.22
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 9.45 (Industry average Stock P/E: 53.42)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.05
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.99%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Non-Banking Financial Company (NBFC) | 21, Netaji Subhas Road, Kolkata West Bengal 700001 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Saurav Dutta | Non Executive Chairman |
| Mr. Arvind Nath Jha | Government Nominee Director |
| Mr. Samir Kumar Mohanty | Government Nominee Director |
FAQ
What is the intrinsic value of Balmer Lawrie Investment Ltd?
Balmer Lawrie Investment Ltd's intrinsic value (as of 24 December 2025) is 64.67 which is 11.41% lower the current market price of 73.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 1,620 Cr. market cap, FY2025-2026 high/low of 95.8/60.0, reserves of ₹1,337 Cr, and liabilities of 3,393 Cr.
What is the Market Cap of Balmer Lawrie Investment Ltd?
The Market Cap of Balmer Lawrie Investment Ltd is 1,620 Cr..
What is the current Stock Price of Balmer Lawrie Investment Ltd as on 24 December 2025?
The current stock price of Balmer Lawrie Investment Ltd as on 24 December 2025 is 73.0.
What is the High / Low of Balmer Lawrie Investment Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Balmer Lawrie Investment Ltd stocks is 95.8/60.0.
What is the Stock P/E of Balmer Lawrie Investment Ltd?
The Stock P/E of Balmer Lawrie Investment Ltd is 9.45.
What is the Book Value of Balmer Lawrie Investment Ltd?
The Book Value of Balmer Lawrie Investment Ltd is 61.2.
What is the Dividend Yield of Balmer Lawrie Investment Ltd?
The Dividend Yield of Balmer Lawrie Investment Ltd is 5.89 %.
What is the ROCE of Balmer Lawrie Investment Ltd?
The ROCE of Balmer Lawrie Investment Ltd is 17.2 %.
What is the ROE of Balmer Lawrie Investment Ltd?
The ROE of Balmer Lawrie Investment Ltd is 13.2 %.
What is the Face Value of Balmer Lawrie Investment Ltd?
The Face Value of Balmer Lawrie Investment Ltd is 1.00.